Gilead Sciences, Inc.
145.65USD
-0.9900 (-0.68%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.14▲ | $1.78 | 5 | 12 |
| Next quarter | $2.19▲ | $2.02 | 3 | 14 |
| Current year | $-0.43▲ | $-0.79 | 23 | 1 |
| Next year | $9.89▲ | $9.59 | 17 | 5 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-7.25 | $-6.75 | +0.50 (+6.9%) |
| 2026-03-31 | $1.91 | $2.03 | +0.12 (+6.2%) |
| 2025-12-31 | $1.81 | $1.86 | +0.05 (+2.8%) |
| 2025-09-30 | $2.14 | $2.47 | +0.33 (+15.7%) |
430 ratings from 45 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Sector Perform | $120 $123 | Aug 5, 2026 |
| Cantor Fitzgerald | Reiterated | Overweight | $155 | Aug 5, 2026 |
| Needham | Reiterated | Buy | $170 | Aug 5, 2026 |
| Barclays | Maintained | Equal-Weight | $155 $145 | Jul 29, 2026 |
| Morgan Stanley | Maintained | Overweight | $166 $165 | Jul 27, 2026 |
| Leerink Partners | Downgraded from Outperform | Market Perform | $146 $127 | Jul 21, 2026 |
| Morgan Stanley | Maintained | Overweight | $168 $166 | Jul 8, 2026 |
| RBC Capital | Maintained | Sector Perform | $122 $120 | Jul 7, 2026 |
| Truist Securities | Maintained | Buy | $157 $156 | Jul 7, 2026 |
| Cantor Fitzgerald | Reiterated | Overweight | $155 | Jul 6, 2026 |
| HSBC | Upgraded from Hold | Buy | $133 $155 | Jul 6, 2026 |
| Cantor Fitzgerald | Reiterated | Overweight | $155 | Jun 16, 2026 |
| Maxim Group | Upgraded from Hold | Buy | $165 | May 20, 2026 |
| Truist Securities | Reiterated | Buy | $155 $157 | May 8, 2026 |
| RBC Capital | Maintained | Sector Perform | $123 $122 | May 8, 2026 |
| Citigroup | Maintained | Buy | $156 $165 | Apr 13, 2026 |
| Morgan Stanley | Maintained | Overweight | $171 $175 | Apr 10, 2026 |
| Jefferies | Initiated | Buy | $180 | Mar 10, 2026 |
| Needham | Reiterated | Buy | $170 | Feb 23, 2026 |
| Barclays | Initiated | Equal-Weight | $155 | Feb 20, 2026 |
| RBC Capital | Maintained | Sector Perform | $103 $118 | Feb 11, 2026 |
| Truist Securities | Maintained | Buy | $145 $152 | Feb 11, 2026 |
| Wells Fargo | Maintained | Overweight | $150 $165 | Feb 11, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $135 $155 | Feb 11, 2026 |
| Scotiabank | Maintained | Sector Outperform | $140 $177 | Feb 11, 2026 |
157 filings from 18 insiders · 22 buy / 20 sell over 6m
Officers and directors of GILD, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| O'Day Daniel PatrickDirector; Officer, Chairman & CEO | Sell | 5.4k | $149.38 | $808k | Sep 1, 2026 |
| O'Day Daniel PatrickDirector; Officer, Chairman & CEO | Sell | 8.0k | $148.36 | $1.19M | Sep 1, 2026 |
| O'Day Daniel PatrickDirector; Officer, Chairman & CEO | Sell | 1.6k | $147.51 | $236k | Sep 1, 2026 |
| WELTERS ANTHONYDirector | Exercise | 18.0k | $60.67 | $1.10M | Aug 26, 2026 |
| WELTERS ANTHONYDirector | Sell | 18.0k | $148.24 | $2.68M | Aug 26, 2026 |
| BLUESTONE JEFFREYDirector | Sell | 5.0k | $143.75 | $725k | Aug 20, 2026 |
| BLUESTONE JEFFREYDirector | Exercise | 5.0k | $61.35 | $335k | Aug 20, 2026 |
| MERCIER JOHANNAOfficer | Exercise | 25.0k | $66.64 | $1.68M | Aug 17, 2026 |
| DICKINSON ANDREW DChief Financial Officer | Sell | 3.0k | $138.36 | $415k | Aug 17, 2026 |
| MERCIER JOHANNAOfficer | Sell | 28.0k | $137.36 | $3.85M | Aug 17, 2026 |
| CAIN WETTAN KEELEY MOfficer | Other | 6.0k | — | — | Aug 10, 2026 |
| O'DAY DANIEL PATRICKChief Executive Officer | Sell | 15.0k | $129.66 | $1.95M | Aug 3, 2026 |
| DICKINSON ANDREW DChief Financial Officer | Sell | 3.0k | $129.93 | $390k | Jul 15, 2026 |
| MERCIER JOHANNAOfficer | Sell | 3.0k | $129.92 | $390k | Jul 15, 2026 |
| O'DAY DANIEL PATRICKChief Executive Officer | Sell | 15.0k | $126.09 | $1.89M | Jul 1, 2026 |
| DICKINSON ANDREW DChief Financial Officer | Sell | 3.0k | $125.40 | $376k | Jun 15, 2026 |
| MERCIER JOHANNAOfficer | Sell | 3.0k | $123.42 | $372k | Jun 15, 2026 |
| CAIN WETTAN KEELEY MGeneral Counsel | Other | 589 | — | — | Jun 10, 2026 |
| MERCIER JOHANNAOfficer | Other | 2.8k | — | — | Jun 10, 2026 |
| O'DAY DANIEL PATRICKChief Executive Officer | Other | 8.8k | — | — | Jun 10, 2026 |
No analyst notes on GILD yet.
Analyst Ratings
27 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 6 | 15 | 6 | 0 | 1 | Buy2.11 |
| 1 mo ago | 6 | 15 | 6 | 0 | 1 | Buy2.11 |
| 2 mo ago | 6 | 16 | 7 | 0 | 0 | Buy2.03 |
| 3 mo ago | 6 | 16 | 7 | 0 | 0 | Buy2.03 |